Mean platelet volume and left ventricular geometry in patients with aortic valve stenosis

References

• Scuteri A, Cacciafesta M, de Propris AM, et al. Platelet size and left ventricular hypertrophy in hypertensive patients over 50 years of age. Eur J Clin Invest 1995;25:874–6
   PubMed Web of Science ®Google Scholar
• Gabbasov Z, Parfyonova Y, Popov E, et al. Association of platelet function in hypertensive patients with left ventricular hypertrophy, transient myocardial ischemia, and coronary artery disease. Platelets 1998;9:191–5
   PubMed Web of Science ®Google Scholar
• Yarlioglues M, Kaya MG, Ardic I, et al. Relationship between mean platelet volume levels and subclinical target organ damage in newly diagnosed hypertensive patients. Blood Press 2011;20:92–7
   PubMed Web of Science ®Google Scholar
• Kennedy KD, Nishimura RA, Holmes DR Jr, Bailey KR. Natural history of moderate aortic stenosis. J Am Coll Cardiol 1991;17:313–19
   PubMed Web of Science ®Google Scholar
• Dimitrow PP, Hlawaty M, Undas A, et al. Effect of aortic valve stenosis on haemostasis is independent from vascular atherosclerotic burden. Atherosclerosis 2009;204:e103–8
   Google Scholar
• Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157–61
   PubMed Web of Science ®Google Scholar
• Dastjerdi MS, Emami T, Najafian A, Amini M. Mean platelet volume measurement, EDTA or citrate? Hematology. 2006;11:317–19
   PubMed Web of Science ®Google Scholar
• Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358–67
   PubMed Web of Science ®Google Scholar
• Otterstad JE, Froeland G, St John Sutton M, Holme I. Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimensions and function. Eur Heart J 1997;18:507–13
   PubMed Web of Science ®Google Scholar
• Lang RM, Bierig M, Devereux RB, et al.; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440–63
   PubMed Web of Science ®Google Scholar
• Takasaki K, Miyata M, Imamura M, et al. Left ventricular dysfunction assessed by cardiac time interval analysis among different geometric patterns in untreated hypertension. Circ J 2012;76:1409–14
   PubMed Web of Science ®Google Scholar
• Vizioli L, Muscari S, Muscari A. The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseases. Int J Clin Pract 2009;63:1509–15
   PubMed Web of Science ®Google Scholar
• Sucu M, Davutoglu V, Sari I, et al. Relationship between platelet indices and aortic valve sclerosis. Clin Appl Thromb Hemost 2010;16:563–7
   PubMed Web of Science ®Google Scholar
• Varol E, Arslan A, Yucel H, et al. Increased mean platelet volume in patients with aortic stenosis. Clin Appl Thromb Hemost 2011;17:e17–20
   Google Scholar
• Natorska J, Bykowska K, Hlawaty M, et al. Increased thrombin generation and platelet activation are associated with deficiency in high molecular weight multimers of von Willebrand factor in patients with moderate-to-severe aortic stenosis. Heart 2011;97:2023–8
   PubMed Web of Science ®Google Scholar
• Wang C, Wu LL, Liu J, et al. Crosstalk between angiotensin II and platelet derived growth factor-BB mediated signal pathways in cardiomyocytes. Chin Med J (Engl) 2008;121:236–40
   PubMed Web of Science ®Google Scholar
• Yabanoglu S, Akkiki M, Seguelas MH, et al. Platelet derived serotonin drives the activation of rat cardiac fibroblasts by 5-HT2A receptors. J Mol Cell Cardiol 2009;46:518–25
   PubMed Web of Science ®Google Scholar
• Antonini-Canterin F, Huang G, Cervesato E, et al. Symptomatic aortic stenosis: does systemic hypertension play an additional role? Hypertension 2003;41:1268–72
   PubMed Web of Science ®Google Scholar
• Fielitz J, Hein S, Mitrovic V, et al. Activation of the cardiac renin–angiotensin system and increased myocardial collagen expression in human aortic valve disease. J Am Coll Cardiol 2001;37:1443–9
   PubMed Web of Science ®Google Scholar
• Nadir MA, Wei L, Elder DH, et al. Impact of renin–angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol 2011;58:570–6
   PubMed Web of Science ®Google Scholar
• Linz W, Schaper J, Wiemer G, et al. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: a one year study in rats. Br J Pharmacol 1992;107:970–5
   PubMed Web of Science ®Google Scholar
• Müller P, Kazakov A, Semenov A, et al. Ramipril and telmisartan exhibit differential effects in cardiac pressure overload-induced hypertrophy without an additional benefit of the combination of both drugs. J Cardiovasc Pharmacol Ther 2013;18:87–93
   PubMed Web of Science ®Google Scholar
• Zhou N, Li L, Wu J, et al. Mechanical stress-evoked but angiotensin II-independent activation of angiotensin II type 1 receptor induces cardiac hypertrophy through calcineurin pathway. Biochem Biophys Res Commun 2010;397:263–9
   PubMed Web of Science ®Google Scholar
• Gul M, Uyarel H, Akgul O, et al. Hematologic and clinical parameters after transcatheter aortic valve implantation (TAVI) in patients with severe aortic stenosis. Clin Appl Thromb Hemost 2014;20:304–10
   PubMed Web of Science ®Google Scholar